Ketamine-induced anesthesia involves the N-methyl-D-aspartate receptor-channel complex in mice

Area of Science:

• Neuroscience
• Anesthesiology
• Pharmacology

Background:

• Ketamine is a widely used anesthetic.
• The N-methyl-D-aspartate (NMDA) receptor-channel complex is a key target for anesthetics.
• Understanding the precise role of NMDA receptors in ketamine's action is crucial for optimizing anesthetic use.

Purpose of the Study:

• To investigate the role of the NMDA receptor-channel complex in ketamine-induced anesthesia.
• To determine if NMDA receptor agonists or antagonists can modulate the anesthetic effects of ketamine.

Main Methods:

• General anesthetic potencies of ketamine were evaluated in mice using a rating scale.
• Drugs including NMDA, N-methyl-L-aspartate, D-cycloserine, kainate, and quisqualate were administered intraperitoneally.
• Anesthetic scores, loss of righting reflex, sleeping time, and recovery time were measured.

Main Results:

• NMDA, an NMDA receptor agonist, dose-dependently antagonized ketamine's anesthetic effects.
• A high dose of N-methyl-L-aspartate, a stereoisomer of NMDA, did not antagonize ketamine.
• D-cycloserine, an agonist at the glycine site of the NMDA receptor, shortened ketamine-induced sleeping time.
• Kainate and quisqualate did not reverse ketamine-induced anesthesia.

Conclusions:

• The NMDA receptor-channel complex plays a significant role in mediating ketamine anesthesia.
• Modulation of NMDA receptor activity can alter the anesthetic potency and duration of ketamine.
• These findings suggest potential for targeting NMDA receptors to fine-tune anesthetic effects.